Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
-
Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Social Media Influence in the Exam Room: National Survey About Medical Testing Reveals Changing Patient Expectations
-
Stardust Power Engages 38 North Solutions To Support Federal Government Relations
-
FreshBooks and Kick Bring Self-Driving Bookkeeping to U.S. Small Businesses
-
TappAlpha and Tuttle Capital Launch the T² Lift™ Series with TSYX and TDAX — Light-Leverage Versions of TSPY and TDAQ Designed to Offer 30% More Exposure to Growth + Income
-
Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation
-
Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy
-
Paul Hollis Confirmed as 41st Director of the United States Mint
-
Kraig Biocraft Laboratories Takes Possession of Three Strategic Mulberry Fields Advancing Massive Spider Silk Production Ramp-Up
-
Oroco Announces Bought Deal Financing Led by Canaccord Genuity
-
Clarios Launches Trailer Battery Manager to Expand Connected Services Platform
-
First Diamond Drill Program Commences at Nobel’s Flagship Cuprita Copper Project, Antofagasta Region, Chile
-
Automotive Industry Veteran Jacob Tilzer and Accrual Equity Partners Launch Gemba Automotive in Arizona
-
Emerita Intersects 2.1m Grading 1.6% Copper, 0.85 g/t Gold, 32.11 g/t Silver and 1.4m Grading 5.8% Copper, 4.89 g/t Gold and 51.0 g/t Silver at El Cura
-
Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects
-
EyePoint Reports Corporate Update and Anticipated Pivotal Milestones for 2026
-
Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance
-
Automotive innovation through open collaboration: momentum builds around open source software as a key driver of efficiency and success
-
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
-
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
-
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
-
BitMart Exchange Announces Partnership with Hit TV-Reality Show CryptoKnights for Season 2
-
Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
-
Barrick to Report Full Year and Fourth Quarter 2025 Results on February 5
-
BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs
-
PAT TILLMAN FOUNDATION ANNOUNCES 22nd ANNUAL PAT’S RUN, PRESENTED BY TEKSYSTEMS
-
Impact Analytics named a Major Player in the 2025–2026 IDC MarketScape for Worldwide Retail Price Optimization Solutions Vendor Assessment
-
CECO Environmental Announces Upcoming Investor Conference
-
Rumble and Tether Launch Crypto Wallet for Creator Economy
-
Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.
-
Dmitry Shubov Supports Southeast Asian Legal Tech Startups in Securing IP Protection for U.S. Market Entry and Success
-
Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX
-
OTC Markets Group Welcomes FUTURE FUELS INC to OTCQX
-
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence
-
Dividend Declaration
-
JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China
-
RaceTrac Partners with ONRAMP to Fight Fraud and Improve Payment Experience at the Pump
-
Castellum, Inc. Announces the Award of a $49.8 Million Recompete Contract to its SSI Subsidiary
-
Titan Machinery Inc. to Present at the 2026 ICR Conference
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Comstock Metals Receives Final Air Quality Permit For Its First-Of-A-Kind, Industrial Scale Solar Panel Processing Facility
-
NOV Announces Fourth Quarter and Full Year 2025 Earnings Conference Call
-
Nova’s RPM North Drilling Confirms Further Resource Upside with East Extension Discovery
-
EnviroGold Delivers Strong 2025 Execution and Establishes a Clear Path to Commercial Growth in 2026
-
Newcore Gold Diamond Drilling Intersects High-Grade Gold Mineralization with 174 g/t Gold over 1.0 Metre and 3.54 g/t Gold over 23.0 Metres, at the Enchi Gold Project, Ghana
